Company Analysis

Immatics N.V. (IMTX)

Nasdaq: IMTX · Biological Products, (No Diagnostic Substances) · Tubingen, DE · filing with the SEC since 2020
Grade5.7
◀ Past 5.4● Present 5.6▶ Future 5.8
7 est.

Income statement, as filed

In thousands of euros (EUR), as filed; per-share figures in euros; share counts. The fiscal year ends in December.
Income statement, by fiscal year, newest first
Fiscal yearFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2020FY 2019FY 2018
Period endingDec 31, 2025Dec 31, 2024Dec 31, 2023Dec 31, 2022Dec 31, 2021Dec 31, 2020Jul 1, 2020Dec 31, 2019Dec 31, 2018
Report filedMar 5, 2026Mar 27, 2025Mar 21, 2024Mar 22, 2023Mar 23, 2022Mar 30, 2021Jul 8, 2020··
Research and development183,832148,079118,663106,77987,57467,085·40,09133,971
General and administrative51,18446,44938,19836,12433,80834,186·11,7567,666
Operating income-182,016-38,615-101,72529,954-86,294-69,715·-33,013-34,409
Finance costs36,6661,3217,040r8,279-1,726r10,063·264161
Finance income18,51644,01813,8509,4165,6752,949·7902,215
Net finance income (costs)-16,42059,9614,73112,082-7,041-142,126r·5262,054
Income before income taxes-198,43621,346-96,99442,036-93,335-211,841r·-32,487-32,355
Income tax expense-1,9896,128-2,345r14,333r00·00
Net income-196,44715,218-94,649r27,703r-93,335-211,841r·-32,487-32,355
Net income to non-controlling interests··00·-557·-916-911
Net income to shareholders··-94,64927,703r-93,335-211,284r·-31,571-31,444
Net income to ordinary shareholders-196,44715,218-94,64927,703·····
Earnings per share, basic-1.610.14-1.18r0.41r-1.48-4.40···
Earnings per share, diluted-1.610.14-1.18r0.40r-1.48-4.40···
Earnings per share, basic and diluted·····-4.40r·-0.95-0.95
Weighted average shares, basic122,348,434105,744,92980,546,68267,220,82462,912,92148,001,228·33,093,83833,093,838
Weighted average shares, diluted122,348,434106,795,10080,546,68268,824,90662,912,92148,001,228···
As filed with the SEC, each figure from the newest report that carries it, and linked to it. Nothing here is computed.A dot is a line not tagged for that period. r restated by the company in a later report; b a share figure put on the newest basis or filed in the wrong unit. Hover a figure for its filing and note.
What each line is, and the XBRL concept behind it
Research and development spent on inventing what it sells nextifrs-full:ResearchAndDevelopmentExpense
General and administrative the cost of running the company itselfifrs-full:GeneralAndAdministrativeExpense
Operating income profit from running the business, before interest and taxifrs-full:ProfitLossFromOperatingActivities
Finance costs what its borrowing costifrs-full:FinanceCosts
Finance income what its cash and investments earnedifrs-full:FinanceIncome
Net finance income (costs) interest earned less interest paid, outside the businessifrs-full:FinanceIncomeCost
Income before income taxes profit before taxifrs-full:ProfitLossBeforeTax
Income tax expense tax charged on the period's profitifrs-full:IncomeTaxExpenseContinuingOperations
Net income the whole group's profit, minority holders' share includedifrs-full:ProfitLoss
Net income to non-controlling interests the share that belongs to minority holdersifrs-full:ProfitLossAttributableToNoncontrollingInterests
Net income to shareholders the profit or loss that belongs to the company's shareholdersifrs-full:ProfitLossAttributableToOwnersOfParent
Net income to ordinary shareholders what is left for common shareholdersifrs-full:ProfitLossAttributableToOrdinaryEquityHoldersOfParentEntity
Earnings per share, basic net income per share outstandingifrs-full:BasicEarningsLossPerShare
Earnings per share, diluted net income per share, counting every share that could be issuedifrs-full:DilutedEarningsLossPerShare
Earnings per share, basic and diluted net income per share, where both counts are the sameifrs-full:BasicAndDilutedEarningsLossPerShare
Weighted average shares, basic the average count of shares outstandingifrs-full:WeightedAverageShares
Weighted average shares, diluted the average count with every share that could be issuedifrs-full:AdjustedWeightedAverageShares
SI Assistanton IMTX · research, not advice